H.I.G.-CAPITAL
H.I.G. Capital (“H.I.G.“), a leading global alternative investment firm with over €36 billion of equity capital under management, is pleased to announce that an affiliate has signed a definitive agreement to sell its German portfolio company WERU Group (the “Company” or “WERU”) to DOVISTA A/S, a leading North European solution provider of vertical windows and exterior doors. The transaction is subject to clearance by the relevant antitrust authorities.
WERU, a leading manufacturer of PVC windows and doors in Germany, was acquired by H.I.G. in 2014, and subsequently acquired UNILUX, a leading manufacturer of wood-based windows and doors to expand its product portfolio. During H.I.G.’s ownership, WERU modernized the Company’s production facilities, launched new products, and implemented various digital innovations. Headquartered near Stuttgart in Germany, WERU sells its product offering via a broad network of more than 1,725 specialized retailers and has more than 1,100 employees across its three manufacturing sites in Germany.
Stefan Löbich, CEO of WERU, commented: “Over the past years, we worked very closely with H.I.G. and successfully implemented our jointly defined strategy. As a result, WERU is a major player within windows and doors in Germany today. Having an experienced, reliable, and financially strong partner such as H.I.G. on our side was extremely beneficial for the Company, and I thank H.I.G. for their continued support. Now I am truly excited to open a new chapter for WERU as part of DOVISTA Group.”
Allan Lindhard Jørgensen, CEO & President of DOVISTA A/S said: “Our two companies make a great fit. With the acquisition of WERU, we accelerate our plans to expand further and truly make all of Europe our home market. We add a notable German vertical windows and exterior doors brand to our existing brand portfolio and gain further traction in Germany which is a significant market for building a strong presence in Central Europe. We are delighted to welcome WERU and its employees to the DOVISTA family, and I very much look forward to working with the WERU team.”
Klaas Reineke, Managing Director at H.I.G., commented: “Working with Stefan Löbich and his team at WERU was a great pleasure for us. We worked closely with WERU management over the past years – with selected add-on acquisitions, continuous digitization efforts, and an even stronger customer focus, and as a result, WERU was able to strengthen its market position in Germany over the last years. We are convinced that WERU is very well positioned for further growth as part of DOVISTA, and we wish Stefan Löbich and his team every success for the future.”
About WERU
WERU is a leading German manufacturer of high-quality windows and external doors of residential buildings with a full range of frame materials and is headquartered in Rudersberg, Baden-Württemberg. WERU offers premium- and luxury products and WERU is perceived as a quality leader in the market. Among its competitors, WERU provides outstanding service quality, lead time, delivery reliability, and after sales support for specialist retailers. WERU has a renowned and distinguished brand, a "Made-in-Germany" reputation and a clear USP. WERU was awarded with "Deutsche Standards - Marke des Jahrhunderts" in 2019.
About DOVISTA
DOVISTA is a leading solution provider of vertical windows and exterior doors made from wood and wood/aluminium on the North European market. DOVISTA was founded in 2004 and is headquartered in Horsens, Denmark and today, more than 4,000 employees manufacture and distribute vertical windows and exterior doors to the core markets: Denmark, Sweden, Norway, the UK, and Ireland.
DOVISTA consists of nine distinctive brands with strong local roots that together represent about 600 years of experience within manufacturing of vertical windows and exterior doors: VELFAC, Rationel, SP Fönster, Traryd Fönster, Mockfjärds, O H Industri, Natre, Lian, and KRONE.
Every DOVISTA brand has its own market strategies, firmly anchored in its local markets, and closely connected to its customers. The brands also collaborate to create knowledge and synergies between the brands and strengthen the shared competences and qualities of the DOVISTA Group.
DOVISTA is part of the VKR Group and thereby, a sister company to VELUX. The VKR Group is owned by VKR Holding A/S, a limited company with a non-profit, charitable foundation as largest shareholder.
For more information, please refer to the DOVISTA website at www.DOVISTA.com .
About H.I.G. Capital
H.I.G. is a leading global alternative assets investment firm with over €36 billion of equity capital under management.* Based in Miami, and with offices in New York, Boston, Chicago, Dallas, Los Angeles, San Francisco, and Atlanta in the U.S., as well as international affiliate offices in London, Hamburg, Madrid, Milan, Paris, Bogotá, Rio de Janeiro and São Paulo, H.I.G. specializes in providing both debt and equity capital to small and mid-sized companies, utilizing a flexible and operationally focused/value-added approach:
1. H.I.G.’s equity funds invest in management buyouts, recapitalizations and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses.
2. H.I.G.’s debt funds invest in senior, unitranche and junior debt financing to companies across the size spectrum, both on a primary (direct origination) basis, as well as in the secondary markets. H.I.G. is also a leading CLO manager, through its WhiteHorse family of vehicles, and manages a publicly traded BDC, WhiteHorse Finance.
3. H.I.G.’s real estate funds invest in value-added properties, which can benefit from improved asset management practices.
Since its founding in 1993, H.I.G. has invested in and managed more than 300 companies worldwide. The firm's current portfolio includes more than 100 companies with combined sales in excess of €27 billion. For more information, please refer to the H.I.G. website at www.higcapital.com .
* Based on total capital commitments managed by H.I.G. Capital and affiliates.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210706005403/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 20268.12.2025 08:00:00 CET | Press release
Merz Therapeutics to present more than 20 abstracts and posters at the TOXINS 2026 8th International Conference, taking place January 14-17 2026 in Madrid, Spain. Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced that the company will present more than 20 clinical and non-clinical abstracts and posters spanning spasticity, movement disorders, and neurotoxin science at the TOXINS 2026 8th International Conference, taking place January 14–17, 2026, in Madrid, Spain. These presentations underscore the company’s commitment to addressing unmet needs in neurological disorders. “Our research reflects a relentless focus on improving patient outcomes through innovation in neurotoxin science,” said Dr. Stefan Albrecht, Chief Scientific and Medical Officer at Merz Therapeutics. “By presenting these new data at TOXINS 2026, we aim to foster scientific exchange and advance treatment strategies that address real-world challenges for patients and clinicians.”
Galderma Welcomes Increased Equity Investment From L’Oréal8.12.2025 07:05:00 CET | Press release
L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers). Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026. In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting. Additio
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 04:37:00 CET | Press release
The Challenge: Deepfakes undermine both the accuracy and fairness of AI face detection due to variations in human features.The Technology: Ant International’s AI model uses a novel ‘Mixture of Experts’-based Adversarial Debiasing approach to achieve superior fairness and accuracy across diverse demographics.The Impact: This advancement strengthens payment security, offering robust protection against deepfake fraud and enhancing eKYC compliance globally. Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the Nati
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
